• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Integrating neurology and pharmacy through telemedicine: A novel care model
Teleneurology had been best studied in acute stroke care, but the Coronavirus (COVID)-19 pandemic has highlighted applicability in outpatient practice. Telepharmacy is a convenient method for pharmacists to provide medication management to enhance care. Studies in the outpatient space suggest non-inferiority of teleneurology to increase access to specialized care for patients in rural locations. The role of telemedicine based interdisciplinary collaborations in a metropolitan and under-resourced setting has not been explored.
Source: Journal of the Neurological Sciences - December 8, 2021 Category: Neurology Authors: Hanlin Li, Imama A. Naqvi, Sarah E. Tom, Barbara Almeida, Yuliya Baratt, Christina M. Ulane Tags: Clinical short communication Source Type: research

Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19
The coronavirus disease 2019 (COVID-19) pandemic started as a respiratory illness. Now, there are increasing reports of its hypercoagulable and thrombotic complications [1] leading to stroke [2,3]. Initial studies suggested strokes to be a feature of severe and late COVID-19 [2,4]; usually occurring in the second week of illness after the onset of typical respiratory symptoms [4]. Recent studies identified these even in mild to moderate infection [5,6]. A recent meta-analysis also noted that 24.5% of patients with stroke symptoms did not experience any of the other typical COVID- 19 symptoms [6].
Source: Journal of the Neurological Sciences - February 16, 2021 Category: Neurology Authors: Rajesh Benny, Rakeshsingh K. Singh, Anil Venkitachalam, Rakesh Shyam Lalla, Rahul A. Pandit, Keyur C. Panchal, Vibhor Pardasani, Gunjan Chanchalani, Mheboob Basle, Vyankatesh Bolegave, Hunnur Manoj, Ashutosh N. Shetty, Amit M. Shah, Pawan Pai, Nilesh M. B Source Type: research

Stroke as a delayed manifestation of multi-organ thromboembolic disease in COVID-19 infection
Here, we report a patient with COVID-19 with delayed onset multi-vessel cerebral infarcts and systemic pro-thrombotic state and coagulopathy manifesting as acute limb ischemia and pulmonary embolism to highlight the importance of vigilant monitoring for neurologic impairment and coagulopathy in patients with severe cases of COVID-19 infection. In December 2019, a cluster of pneumonia cases emerged in Wuhan, Hubei Province; later identified as a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19).
Source: Journal of the Neurological Sciences - July 28, 2020 Category: Neurology Authors: Jay L. Liu, Ayaz M. Khawaja, Ariel Q. Majjhoo Tags: Letter to the Editor Source Type: research

Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
An increasing body of evidence suggests that the coronavirus disease 2019 (SARS-CoV2) may be associated with cerebrovascular disease, although most cases have been ischemic strokes related to occlusion of major intracranial vessels [1 –3]. Intracranial hemorrhages in the setting of SARS-CoV2 infection are exceedingly rare. To the best of our knowledge, only two cases has been reported in detail, one with a massive parenchymal brain hemorrhage and the other with an aneurysmal subarachnoid hemorrhage [4,5].
Source: Journal of the Neurological Sciences - July 14, 2020 Category: Neurology Authors: P.R. Castillo, O.H. Del Brutto, H. Mautong, M. Garc ía, M. Tovar, E.H. Middlebrooks, E. Bologna Tags: Letter to the Editor Source Type: research

COVID-19 AND STROKE: Experience in a GHANAIAN healthcare system
Background:The novel coronavirus disease 19 (COVID-19) causes multi-system disease including possibly heightened stroke risk. Data from high-income countries (HIC) suggest disruptions to care delivery with reduced stroke admissions and administration of acute stroke reperfusion therapies. We are unaware of any published data on the impact of the COVID-19 pandemic on stroke admissions and outcomes in sub-Saharan Africa.Purpose: To compare rates of stroke admissions and case fatality between corresponding periods in 2020 and 2019, within a hospital system in Ghana, to assess the potential impact of the COVID-19 pandemic.
Source: Journal of the Neurological Sciences - July 14, 2020 Category: Neurology Authors: Fred S. Sarfo, Naa Oboshie Mensah, Francis Agyapong Opoku, Nathaniel Adusei-Mensah, Michael Ampofo, Bruce Ovbiagele Source Type: research

Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
Stroke and cardiovascular diseases are the world's biggest killers, globally accounting for over 15 million deaths each year (https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death). Since the Coronavirus Disease 2019 (COVID-19) outbreak in Wuhan, China and its rapid spread to other countries, as of April 272,020, there were about 3 million cases with over 190,000 deaths worldwide. However, actual situation might be even more dire, since such statistics likely do not fully display the entire impact of COVID-19, especially with regard to its influence on patients with a history of stroke who need to tak...
Source: Journal of the Neurological Sciences - May 5, 2020 Category: Neurology Authors: Meng Lee, Chi-Hsin Sally Chen, Bruce Ovbiagele Tags: Letter to the Editor Source Type: research